Molecular typing indicates an important role for two international clonal complexes in dissemination of VIM-producing Pseudomonas aeruginosa clinical isolates in Hungary

Research in Microbiology

Volumn 159, Issue 3, 2008, Pages 162-168

  Libisch, Balázs ^a   Watine, Joseph ^b   Balogh, Boglárka ^a   Gacs, Mária ^a   Muzslay, Mónika ^a   Szabó, Gitta ^a   Füzi, Miklós ^a  

^a NATIONAL CENTER FOR EPIDEMIOLOGY   (Hungary)

^b HÔPITAL DU BOCAGE   (France)

Author keywords

Carbapenem; CC11; CC4; Clonal complex; Metallo lactamase; MLST; P12 clone; Pseudomonas aeruginosa; Serotype

Indexed keywords

METALLO BETA LACTAMASE;

ARTICLE; GENE CASSETTE; GENE SEQUENCE; HUNGARY; INTEGRON; INTERNATIONAL CLONAL COMPLEX; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR CLONING; MOLECULAR TYPING; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; SEROTYPE;

BACTERIAL TYPING TECHNIQUES; BETA-LACTAMASES; DRUG RESISTANCE, BACTERIAL; HUMANS; HUNGARY; INTEGRONS; MICROBIAL SENSITIVITY TESTS; MOLECULAR SEQUENCE DATA; PHENOTYPE; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; RANDOM AMPLIFIED POLYMORPHIC DNA TECHNIQUE; SEQUENCE ANALYSIS, DNA;

PSEUDOMONAS; PSEUDOMONAS AERUGINOSA;

EID: 41849100397     PISSN: 09232508     EISSN: 17697123     Source Type: Journal    
DOI: 10.1016/j.resmic.2007.12.008     Document Type: Article

References (35)

1. Boucher Y., Labbate M., Koenig J.E., and Stokes H.W. Integrons: mobilizable platforms that promote genetic diversity in bacteria. Trends in Microbiology 15 (2007) 301-309
2. Brisse S., Milatovic D., Fluit A.C., Kusters K., Toelstra A., Verhoef J., et al. Molecular surveillance of European quinolone-resistant clinical isolates of Pseudomonas aeruginosa and Acinetobacter spp. using automated ribotyping. Journal of Clinical Microbiology 38 (2000) 3636-3645
3. Canton R., Coque T.M., and Baquero F. Multi-resistant Gram-negative bacilli: from epidemics to endemics. Current Opinion in Infectious Diseases 16 (2003) 315-325
4. Carvalho A.P., Albano R.M., de Oliveira D.N., Cidade D.A., Teixeira L.M., and Marques Ede A. Characterization of an epidemic carbapenem-resistant Pseudomonas aeruginosa producing SPM-1 metallo-β-lactamase in a hospital located in Rio de Janeiro, Brazil. Microbial Drug Resistance 12 (2006) 103-108
5. Clinical and Laboratory Standards Institute (CLSI). Standards for antimicrobial susceptibility testing sixteenth informational supplement M100-BS16 (2006), CLSI, Wayne, PA, US
6. Collis C.M., Recchia G.D., Kim M.J., Stokes H.W., and Hall R.M. Efficiency of recombination reactions catalyzed by class 1 integron integrase IntI1. Journal of Bacteriology 183 (2001) 2535-2542
7. Crespo M.P., Woodford N., Sinclair A., Kaufmann M.E., Turton J., Glover J., et al. Outbreak of carbapenem-resistant Pseudomonas aeruginosa producing VIM-8, a novel metallo-β-lactamase, in a tertiary care center in Cali, Colombia. Journal of Clinical Microbiology 42 (2004) 5094-5101
8. Curran B., Jonas D., Grundmann H., Pitt T., and Dowson C.G. Development of a multilocus sequence typing scheme for the opportunistic pathogen Pseudomonas aeruginosa. Journal of Clinical Microbiology 42 (2004) 5644-5649
9. Empel J., Filczak K., Mrowka A., Hryniewicz W., Livermore D.M., and Gniadkowski M. Outbreak of Pseudomonas aeruginosa with PER-1 extended-spectrum-β-lactamase in Warsaw, Poland; further evidence for an international clonal complex. Journal of Clinical Microbiology 45 (2007) 2829-2834
10. Feil E.J., Li B.C., Aanensen D.M., Hanage W.P., and Spratt B.G. eBURST: inferring patterns of evolutionary descent among clusters of related bacterial genotypes from multilocus sequence typing data. Journal of Bacteriology 186 (2004) 1518-1530
11. Giske C.G., Libisch B., Colinon C., Scoulica E., Pagani L., Fuzi M., et al. Establishing clonal relationships between VIM-1-like metallo-β-lactamase-producing Pseudomonas aeruginosa strains from four European countries by multilocus sequence typing. Journal of Clinical Microbiology 44 (2006) 4309-4315
12. Goering R.V., and Tenover F.C. Epidemiological interpretation of chromosomal macro-restriction fragment patterns analyzed by pulsed-field gel electrophoresis. Journal of Clinical Microbiology 35 (1997) 2432-2433
13. IMP-4 at a 320-bed tertiary hospital in Australia. Infection Control and Hospital Epidemiology 28 (2007) 98-101
14. Johnson J.K., Arduino S.M., Stine O.C., Johnson J.A., and Harris A.D. Multilocus sequence typing compared to pulsed-field gel electrophoresis for molecular typing of Pseudomonas aeruginosa. Journal of Clinical Microbiology 45 (2007) 3707-3712
15. Lagatolla C., Tonin E.A., Monti-Bragadin C., Dolzani L., Gombac F., Bearzi C., et al. Endemic carbapenem-resistant Pseudomonas aeruginosa with acquired metallo-β-lactamase determinants in European hospital. Emerging Infectious Diseases 10 (2004) 535-538
16. Laupland K.B., Parkins M.D., Church D.L., Gregson D.B., Louie T.J., Conly J.M., et al. Population-based epidemiological study of infections caused by carbapenem-resistant Pseudomonas aeruginosa in the Calgary health region: importance of metallo-β-lactamase (MBL)-producing strains. Journal of Infectious Diseases 19 (2005) 21606-21612
17. VIM, a new integron-borne metallo-β-lactamase gene from a Pseudomonas aeruginosa clinical isolate. Antimicrobial Agents and Chemotherapy 43 (1999) 1584-1590
18. VIM-4 type metallo-β-Lactamase gene from a carbapenem-resistant Pseudomonas aeruginosa clinical isolate in Hungary. Antimicrobial Agents and Chemotherapy 48 (2004) 3576-3578
19. Libisch B., Muzslay M., Gacs M., Minarovits J., Knausz M., Watine J., et al. Molecular epidemiology of VIM-4 metallo-β-lactamase-producing Pseudomonas sp. isolates in Hungary. Antimicrobial Agents and Chemotherapy 50 (2006) 4220-4223
20. Lolans K., Queenan A.M., Bush K., Sahud A., and Quinn J.P. First nosocomial outbreak of Pseudomonas aeruginosa producing an integron-borne metallo-β-lactamase (VIM-2) in the United States. Antimicrobial Agents and Chemotherapy 49 (2005) 3538-3540
21. Mifsud A.J., Watine J., Picard B., Charet J.C., Solignac-Bourrel C., and Pitt T.L. Epidemiologically related and unrelated strains of Pseudomonas aeruginosa serotype O12 cannot be distinguished by phenotypic and genotypic typing. Journal of Hospital Infection 36 (1997) 105-116
22. Partridge S.R., Brown H.J., and Hall R.M. Characterization and movement of the class 1 integron known as Tn2521 and Tn1405. Antimicrobial Agents and Chemotherapy 46 (2002) 1288-1294
23. VIM-4 gene cassette isolated from hospitalized children in Poland (1998-2001). Journal of Antimicrobial Chemotherapy 53 (2004) 451-456
24. Pitt T.L., Livermore D.M., Pitcher D., Vatopoulos A.C., and Legakis N.J. Multiresistant serotype O12 Pseudomonas aeruginosa: evidence for a common strain in Europe. Epidemiology and Infection 103 (1989) 565-576
25. Poh C.L., Yeo C.C., and Tay L. Genome fingerprinting by pulsed-field gel electrophoresis and ribotyping to differentiate Pseudomonas aeruginosa serotype O11 strains. European Journal of Clinical Microbiology and Infectious Diseases 11 (1992) 817-822
26. Poirel L., and Nordmann P. Acquired carbapenem-hydrolyzing β-lactamases and their genetic support. Current Pharmaceutical Biotechnology 3 (2002) 117-127
27. Poirel L., Naas T., Nicolas D., Collet L., Bellais S., Cavallo J.D., et al. Characterization of VIM-2, a carbapenem-hydrolyzing metallo-β-lactamase and its plasmid- and integron-borne gene from a Pseudomonas aeruginosa clinical isolate in France. Antimicrobial Agents and Chemotherapy 44 (2000) 891-897
28. REUSSIR (Réseau épidémiologique des utilisateurs du système SIR). Le portage prolongé et la diffusion clonale interhospitaliére des Pseudomonas aeruginosa multirésistants de sérotype O12 sont-ils liés? Étude multicentrique. Pathologie Biologie 49 (2001) 620-623
29. Rossolini G.M. Acquired metallo-β-lactamases: an increasing clinical threat. Clinical Infectious Diseases 41 (2005) 1557-1558
30. Scott F.W., and Pitt T.L. Identification and characterization of transmissible Pseudomonas aeruginosa strains in cystic fibrosis patients in England and Wales. Journal of Medical Microbiology 53 (2004) 609-615
31. VIM-1 metallo-β-lactamase gene. Diagnostic Microbiology and Infectious Disease 48 (2004) 167-172
32. Speijer H., Savelkoul P.H., Bonten M.J., Stobberingh E.E., and Tjhie J.H. Application of different genotyping methods for Pseudomonas aeruginosa in a setting of endemicity in an intensive care unit. Journal of Clinical Microbiology 37 (1999) 3654-3661
33. Walsh T.R., Toleman M.A., Poirel L., and Nordmann P. Metallo-β-lactamases: the quiet before the storm?. Clinical Microbiology Reviews 18 (2005) 306-325
34. Yan J.J., Wu J.J., Tsai S.H., and Chuang C.L. Comparison of the double-disk, combined disk, and Etest methods for detecting metallo-β-lactamases in gram-negative bacilli. Diagnostic Microbiology and Infectious Disease 49 (2004) 5-11
35. Yu Y.S., Qu T.T., Zhou J.Y., Wang J., Li H.Y., and Walsh T.R. Integrons containing the VIM-2 metallo-β-lactamase gene among imipenem-resistant Pseudomonas aeruginosa strains from different Chinese hospitals. Journal of Clinical Microbiology 44 (2006) 4242-4245